AQR Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Sell |
3,167
-605
| -16% | -$183K | ﹤0.01% | 2230 |
|
|
2025
Q1 | $1.25M | Sell |
3,772
-1,710
| -31% | -$566K | ﹤0.01% | 1883 |
|
|
2024
Q4 | $1.69M | Buy |
5,482
+364
| +7% | +$112K | ﹤0.01% | 1622 |
|
|
2024
Q3 | $1.09M | Buy |
5,118
+508
| +11% | +$108K | ﹤0.01% | 1805 |
|
|
2024
Q2 | $1.29M | Sell |
4,610
-695
| -13% | -$195K | ﹤0.01% | 1641 |
|
|
2024
Q1 | $1.42M | Sell |
5,305
-808
| -13% | -$216K | ﹤0.01% | 1554 |
|
|
2023
Q4 | $1.41M | Sell |
6,113
-113
| -2% | -$26.1K | ﹤0.01% | 1479 |
|
|
2023
Q3 | $909K | Sell |
6,226
-301
| -5% | -$44K | ﹤0.01% | 1634 |
|
|
2023
Q2 | $1.51M | Sell |
6,527
-154
| -2% | -$35.6K | ﹤0.01% | 1390 |
|
|
2023
Q1 | $1.62M | Buy |
6,681
+4,796
| +254% | +$1.16M | ﹤0.01% | 1336 |
|
|
2022
Q4 | $547K | Buy |
+1,885
| New | +$547K | ﹤0.01% | 1783 |
|
|
2019
Q1 | – | Sell |
-4,955
| Closed | -$559K | – | 2193 |
|
|
2018
Q4 | $559K | Sell |
4,955
-2,086
| -30% | -$235K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $1.51M | Sell |
7,041
-4,749
| -40% | -$1.02M | ﹤0.01% | 1520 |
|
|
2018
Q2 | $3.3M | Buy |
11,790
+6,052
| +105% | +$1.69M | ﹤0.01% | 1199 |
|
|
2018
Q1 | $670K | Buy |
+5,738
| New | +$670K | ﹤0.01% | 1820 |
|
|
2013
Q4 | – | Sell |
-774
| Closed | -$171K | – | 2586 |
|
|
2013
Q3 | $171K | Sell |
774
-1,660
| -68% | -$367K | ﹤0.01% | 2370 |
|
|
2013
Q2 | $425K | Buy |
+2,434
| New | +$425K | ﹤0.01% | 1958 |
|